Here’s a bleak number for you: 95 percent of biopharmaceutical companies fail. According to Johns Hopkins’ Lynn Johnson Langer, that’s in part because, traditionally, “business people and scientists didn’t speak each other’s language. They didn’t always respect each other.” Langer knew about the conflict better than most: she started out as a microbiologist at the […]
Become a Baltimore Fishbowl Member
Your contributions help pay for current editorial costs and to expand our community coverage
